Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gomez

Showing results (941-950 of 1,088) with videos related to

Pageof 109
Sort By:
Journal for Immunotherapy of Cancer|November 1, 2023
Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancerJoao V Alessi, Adam Price, Allison L Richards, et al.
Cancer Research|November 9, 2016
Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by RadiotherapyXiaohong Wang, Jonathan E Schoenhals, Ailin Li, et al.
Journal of the National Cancer Institute|July 28, 2019
Sex-Based Disparities Among Cancer Clinical Trial ParticipantsEthan B Ludmir, C David Fuller, Shalini Moningi, et al.
Gynecologic Oncology|November 30, 2019
Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomyMario M Leitao, Qin C Zhou, Natalia R Gomez-Hidalgo, et al.
Cancer Treatment and Research Communications|January 20, 2022
Phase I Trial of Definitive Concurrent Chemoradiotherapy and Trametinib for KRAS-Mutated Non-Small Cell Lung CancerSteven H Lin, Heather Y Lin, Vivek Verma, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2023
Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation TrialAndreas Rimner, Daphna Y Gelblum, Abraham J Wu, et al.
Practical Radiation Oncology|June 16, 2026
Prophylactic versus therapeutic sucralfate in patients at high risk for radiation esophagitis: randomized controlled trialJacob Y Shin, Melissa Assel, Abraham J Wu, et al.
Cancer Immunology Research|August 4, 2023
Tumor-Targeted Nonablative Radiation Promotes Solid Tumor CAR T-cell Therapy EfficacyHue Tu Quach, Matthew S Skovgard, Jonathan Villena-Vargas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2022
Systemic and Oligo-Acquired Resistance to PD-(L)1 Blockade in Lung CancerAdam J Schoenfeld, Hira A Rizvi, Danish Memon, et al.
JAMA Oncology|September 19, 2019
Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal CancerDawei Chen, Hari Menon, Vivek Verma, et al.
Pageof 109

Showing results (941-950 of 1,088) with videos related to

Sort By:
Pageof 109
Journal for Immunotherapy of Cancer|November 1, 2023
Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancerJoao V Alessi, Adam Price, Allison L Richards, et al.
Cancer Research|November 9, 2016
Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by RadiotherapyXiaohong Wang, Jonathan E Schoenhals, Ailin Li, et al.
Journal of the National Cancer Institute|July 28, 2019
Sex-Based Disparities Among Cancer Clinical Trial ParticipantsEthan B Ludmir, C David Fuller, Shalini Moningi, et al.
Gynecologic Oncology|November 30, 2019
Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomyMario M Leitao, Qin C Zhou, Natalia R Gomez-Hidalgo, et al.
Cancer Treatment and Research Communications|January 20, 2022
Phase I Trial of Definitive Concurrent Chemoradiotherapy and Trametinib for KRAS-Mutated Non-Small Cell Lung CancerSteven H Lin, Heather Y Lin, Vivek Verma, et al.
International Journal of Radiation Oncology, Biology, Physics|December 28, 2023
Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation TrialAndreas Rimner, Daphna Y Gelblum, Abraham J Wu, et al.
Practical Radiation Oncology|June 16, 2026
Prophylactic versus therapeutic sucralfate in patients at high risk for radiation esophagitis: randomized controlled trialJacob Y Shin, Melissa Assel, Abraham J Wu, et al.
Cancer Immunology Research|August 4, 2023
Tumor-Targeted Nonablative Radiation Promotes Solid Tumor CAR T-cell Therapy EfficacyHue Tu Quach, Matthew S Skovgard, Jonathan Villena-Vargas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2022
Systemic and Oligo-Acquired Resistance to PD-(L)1 Blockade in Lung CancerAdam J Schoenfeld, Hira A Rizvi, Danish Memon, et al.
JAMA Oncology|September 19, 2019
Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal CancerDawei Chen, Hari Menon, Vivek Verma, et al.
Pageof 109